| TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
| Glucose metabolism | R-HSA-70326 | 6.77 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 9.52 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Signaling by NOTCH | R-HSA-157118 | 6.2 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.83 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.59 |
| Cell Cycle | R-HSA-1640170 | 3.89 |
| Association of licensing factors with the pre-replicative complex | R-HSA-69298 | 9.08 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.1 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.73 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.85 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.66 |
| Generic Transcription Pathway | R-HSA-212436 | 3.86 |
| degradation of DVL | R-HSA-4641258 | 7.18 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.32 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
| Cellular responses to stress | R-HSA-2262752 | 4.56 |
| HIV Infection | R-HSA-162906 | 5.22 |
| IRS-mediated signalling | R-HSA-112399 | 4.87 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.73 |
| Regulation of Apoptosis | R-HSA-169911 | 7.34 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.85 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.02 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.15 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.56 |
| Interferon Signaling | R-HSA-913531 | 4.95 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.15 |
| TCR signaling | R-HSA-202403 | 6.64 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.08 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.92 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.72 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.81 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.18 |
| Glycogen storage diseases | R-HSA-3229121 | 9.52 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.18 |
| Interleukin-2 signaling | R-HSA-451927 | 5.05 |
| beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.28 |
| NIK--noncanonical NF-kB signaling | R-HSA-5676590 | 7.12 |
| MAP kinase activation in TLR cascade | R-HSA-450294 | 7.28 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.98 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.37 |
| MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.65 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.98 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.08 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.98 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.98 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.33 |
| Cellular response to hypoxia | R-HSA-2262749 | 8.4 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.08 |
| G1/S Transition | R-HSA-69206 | 6.21 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.36 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.15 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.15 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.96 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.23 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.08 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 |
| p53-Independent DNA Damage Response | R-HSA-69610 | 7.28 |
| p53-Independent G1/S DNA damage checkpoint | R-HSA-69613 | 7.28 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.59 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.08 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.1 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.66 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.46 |
| Immune System | R-HSA-168256 | 2.37 |
| Frs2-mediated activation | R-HSA-170968 | 5.12 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.15 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.87 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.28 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | R-HSA-5362768 | 7.2 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.79 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.15 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.31 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.18 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.81 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.45 |
| CDT1 association with the CDC6:ORC:origin complex | R-HSA-68827 | 7.12 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.12 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.15 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.28 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.31 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.15 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.16 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.85 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.28 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.08 |
| G2/M Transition | R-HSA-69275 | 6.06 |
| Interleukin-1 signaling | R-HSA-446652 | 7.52 |
| Mitotic G1-G1/S phases | R-HSA-453279 | 5.91 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.59 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.09 |
| TRAF6 mediated induction of TAK1 complex | R-HSA-937072 | 8.98 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.99 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.34 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.04 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.25 |
| DNA Repair | R-HSA-73894 | 5.8 |
| Glycogen synthesis | R-HSA-3322077 | 9.08 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
| Mitotic Anaphase | R-HSA-68882 | 5.46 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.61 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.28 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Prolonged ERK activation events | R-HSA-169893 | 5.11 |
| degradation of AXIN | R-HSA-4641257 | 7.23 |
| Signaling by Wnt | R-HSA-195721 | 4.79 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.28 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.66 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.59 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.03 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.46 |
| Signaling by VEGF | R-HSA-194138 | 4.66 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.98 |
| Removal of licensing factors from origins | R-HSA-69300 | 6.81 |
| Axon guidance | R-HSA-422475 | 3.93 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
| M/G1 Transition | R-HSA-68874 | 6.62 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | R-HSA-936964 | 8.81 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.03 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.31 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.51 |
| Cellular Senescence | R-HSA-2559583 | 5.7 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.77 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
| Signaling by Leptin | R-HSA-2586552 | 5.1 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.52 |
| Programmed Cell Death | R-HSA-5357801 | 5.65 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.66 |
| RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
| deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.59 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.73 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.34 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.18 |
| M Phase | R-HSA-68886 | 4.87 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
| Disease | R-HSA-1643685 | 3.33 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
| Regulation of the Fanconi anemia pathway | R-HSA-419552 | 9.66 |
| Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.18 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| Metabolism of carbohydrates | R-HSA-71387 | 4.93 |
| Gene Expression | R-HSA-74160 | 2.72 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.88 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.08 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.98 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.89 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.18 |
| Stabilization of p53 | R-HSA-69541 | 7.28 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 9.28 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.98 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.56 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.46 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.03 |
| Infectious disease | R-HSA-5663205 | 4.47 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.15 |
| Downstream TCR signaling | R-HSA-202424 | 7.01 |
| AUF1 (hnRNP D0) destabilizes mRNA | R-HSA-450408 | 7.23 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.15 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.81 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.81 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.85 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.89 |
| Regulation of Hypoxia-inducible Factor (HIF) by oxygen | R-HSA-1234174 | 8.4 |
| Signalling to RAS | R-HSA-167044 | 5.08 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.43 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.08 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.15 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.62 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 |
| Circadian Clock | R-HSA-400253 | 7.03 |
| G2/M Checkpoints | R-HSA-69481 | 6.46 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.64 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.98 |
| EGFR downregulation | R-HSA-182971 | 8.28 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.94 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.15 |
| PCP/CE pathway | R-HSA-4086400 | 6.47 |
| ARMS-mediated activation | R-HSA-170984 | 5.12 |
| S Phase | R-HSA-69242 | 6.02 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.15 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.62 |
| MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
| Activated TLR4 signalling | R-HSA-166054 | 6.27 |
| DNA Damage Bypass | R-HSA-73893 | 7.46 |
| Ion channel transport | R-HSA-983712 | 5.34 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.01 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.55 |
| Signaling by Interleukins | R-HSA-449147 | 4.71 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.08 |
| Transmembrane transport of small molecules | R-HSA-382551 | 3.79 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.12 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| SOS-mediated signalling | R-HSA-112412 | 5.15 |
| Metabolism | R-HSA-1430728 | 2.34 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.1 |
| regulation of FZD by ubiquitination | R-HSA-4641263 | 8.59 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.89 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.61 |
| Diseases of metabolism | R-HSA-5668914 | 6.57 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.4 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.19 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.83 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.52 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.89 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.2 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.05 |
| G1 Phase | R-HSA-69236 | 7.73 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
| Regulation of DNA replication | R-HSA-69304 | 6.75 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.73 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.15 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.64 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Synthesis of DNA | R-HSA-69239 | 6.37 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.1 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.54 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.28 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.98 |
| Membrane Trafficking | R-HSA-199991 | 5.26 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.98 |
| Negative regulators of RIG-I/MDA5 signaling | R-HSA-936440 | 7.98 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.87 |
| Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.52 |
| Regulated Necrosis | R-HSA-5218859 | 8.81 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.77 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.73 |
| Fanconi Anemia pathway | R-HSA-419524 | 8.4 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.66 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.92 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| Signaling by GPCR | R-HSA-372790 | 2.68 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.79 |
| Signalling to ERKs | R-HSA-187687 | 5.04 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.08 |
| DNA Replication | R-HSA-69306 | 6.25 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.19 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.34 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| HIV Life Cycle | R-HSA-162587 | 5.89 |
| Ubiquitin-dependent degradation of Cyclin D1 | R-HSA-69229 | 7.34 |
| Apoptosis | R-HSA-109581 | 5.68 |